Header Logo

Connection

Gary Schaer to Chemokine CXCL12

Back to Details
This is a "connection" page, showing publications Gary Schaer has written about Chemokine CXCL12.
Gary Schaer
Connection Strength
0.109
Chemokine CXCL12
  1. An open-label dose escalation study to evaluate the safety of administration of nonviral stromal cell-derived factor-1 plasmid to treat symptomatic ischemic heart failure. Circ Res. 2013 Mar 01; 112(5):816-25.
    View in: PubMed
    Score: 0.109
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.